' fill='%23ffffff'%3E%3Cpath d='M283.94,167.31l386.39,516.64L281.5,1104h87.51l340.42-367.76L984.48,1104h297.8L874.15,558.3l361.92-390.99 h-87.51l-313.51,338.7l-253.31-338.7H283.94z M412.63,231.77h136.81l604.13,807.76h-136.81L412.63,231.77z'%3E%3C/path%3E%3C/g%3E%3C/svg%3E%0A){kind=small}
Search result
Ruth Valentine
Genetics and Rare Diseases
Our role is to support the delivery of high-quality clinical research in Genetics and manage participant recruitment to time and target, both for Genetics studies which are led from Scotland, and studies led from other nations which Scottish sites are participating in. We provide support in the following areas: Managing the study portfolio Monitoring the attainment of recruitment targets Providing advice on study design and feasibility Troubleshoo...
Rebecca Skillen
Kirsty Hynes
Good Research Practice (Non-drug Trials)
Pay by Cheque: please make out a cheque, payable to NHS GG& C Endowment Fund CG0337 and bring it with you on the day. Pay by Credit or Debit Card: can be arranged. (Please note your details will be stored in our database but not passed on to any other parties). If you have any queries in respect of your course fee, please telephone 0141 201 9324. Thank you.
Haematology
For specific Coronavirus (COVID-19) research and guidance visit the Coronavirus information hub. Our role is to support the delivery of high quality clinical research in Haematology Disorders and manage participant recruitment to time and target, both for studies which are led from Scotland, and studies led from other nations which Scottish sites are participating in. We...
Good Research Practice (Non-Drug Trials)
Pay by Cheque: please make out a cheque, payable to NHS GG& C Endowment Fund CG0337 and bring it with you on the day. Pay by Credit or Debit Card: can be arranged. (Please note your details will be stored in our database but not passed on to any other parties). If you have any queries in respect of your course fee, please telephone 0141 201 9324. Thank you.
‘VPAG boost is ultimately about better patient outcomes across Scotland and realising true value’
The Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG) must ultimately be about realising true value for the benefit of patients, says NHS Research Scotland (NRS) Last year, it was announced that £100m in public-private investment from pharmaceutical companies would deliver 20 research hubs across the UK as part of the wider £400 million VPAG scheme. Under its accompanying investment programme, Commercial Research Delivery Centres (CRDCs) will...
Kim Stringer
Blog
NHS Research Scotland blogs cover elements of clinical research in Scotland in more depth, and feature writing from those directly involved in key studies taking place across the country. If you are interested in featuring on the NRS blog, or have general queries, please contact communications@nrs.org.uk.
